Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Cu-mediated Radiocyanation with [11C]KCN for the Preparation of [11C]LY2795050, a Selective Kappa Opioid Antagonist

Allen Brooks, Katarina Makaravage, Xia Shao, Sarah Burris, Melanie Sanford and Peter Scott
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 402;
Allen Brooks
1University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katarina Makaravage
1University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xia Shao
1University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Burris
1University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie Sanford
1University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Scott
1University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

402

Objectives: The ability to use the same precursor with multiple radioisotopes greatly expands the possibilities for potential imaging agents and provides a means to produce compound libraries from a common intermediate. Our objective was to expand our previously developed [18F]fluorination methodology of arylstannanes[1] to [11C]cyanation and use the method to prepare [11C]LY2795050, a selective kappa opioid antagonist[2].

Methods: For the non-isotopically modified method, all reagents were combined in a glovebox and allowed to stir at 100 °C for 15 min. After cooling to room temperature, yields were analyzed by NMR. For the radiochemistry, [11C]benzonitrile derivatives were prepared in a TRACERlab FXM from arylstannane precursor through an automated procedure based on adaptation of the previously reported [18F]fluorination synthetic route[1] and [11C]HCN trap and elute technique[3]. [11C]HCN was prepared and trapped on a platinum wire coated with 0.5 M KOH. To remove excess NH3, vacuum was applied. The resulting [11C]KCN was eluted with 1 mL of water, azeotropically dried with acetonitrile, and dissolved in the reaction solvent. Arylstannane precursor and copper pyridine complex were then added and heated to generate carbon-11 labeled product. The [11C]cyano intermediate of [11C]LY2795050 was then converted as previously reported to give the desired amide product[2].

Results: Preliminary studies show that 4-fluorobenzonitrile can be obtained in 48% 19F NMR yield in 15 min, and that [11C]4-methoxybenzonitrile was obtained in 30% HPLC-RCY non-decay corrected. In the two step preparation of [11C]LY2795050, the method was able to produce 38 mCi (9.5% HPLC-RCY; non-decay corrected from 400 mCi of [11C]KCN) of desired product. In addition, the arylstannane precursor for LY2795050 could be fluorine-18 labeled in 9.4% HPLC-RCY non-decay corrected (see Figure).

Conclusion: We report a radiochemical method for synthesizing benzonitrile substrates and radiolabeling [11C]benzonitrile substrates from [11C]KCN, including [11C]LY2795050. It is demonstrated that arylstanane precursors can be used for [18F]fluorination or [11C]cyanation radiolabeling and give comparable yields. Future studies include exploring the scope of this transformation and improving the automation procedure. References: [1] Sanford, M. S.; Scott, P. J. H.; et. al. Org. Lett. 2016, 18, 5440-5443; [2] Zheng, M.; Huang, Y.; et. al. J. Nucl. Med. 2013, 54,455-463. [3] Carroll, V. N.; Shao, X.; et. al. Chem. Commun., 2016,52, 4888-4890. Research Support: This work was supported by the NIH (R01EB021155).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cu-mediated Radiocyanation with [11C]KCN for the Preparation of [11C]LY2795050, a Selective Kappa Opioid Antagonist
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cu-mediated Radiocyanation with [11C]KCN for the Preparation of [11C]LY2795050, a Selective Kappa Opioid Antagonist
Allen Brooks, Katarina Makaravage, Xia Shao, Sarah Burris, Melanie Sanford, Peter Scott
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 402;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cu-mediated Radiocyanation with [11C]KCN for the Preparation of [11C]LY2795050, a Selective Kappa Opioid Antagonist
Allen Brooks, Katarina Makaravage, Xia Shao, Sarah Burris, Melanie Sanford, Peter Scott
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 402;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Novel Radiochemistry - Non-Metal Radionuclides

  • Access to NCA 11C-Labeled (Trifluoromethylthiol)arenes through Treatment of Aryl Disulfides with [11C]Fluoroform
  • Nickel(II) Catalyzed Synthesis of Arylboron and Arylstannane [18F]Fluorination Precursors from Aryl Fluoride Reference Standards
  • Labeling an anti-HER2 VHH with 18F using a residualizing prosthetic group via strain-promoted click reaction: preliminary evaluation
Show more Novel Radiochemistry - Non-Metal Radionuclides

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire